November 3, 2017 1:08pm

 

Financial results also known as (AKA) earnings is a ‘scorecard’ of public stem, cell, gene and regenerative therapy's companies.

 

The current LPS (loss per share) standings reflect the universes’ investing status; then add in their cash position for a better snapshot!

By analyzing these comparisons, investors can begin to gauge the financial health versus the scientific opportunity and whether or not it deserves their investment.


COMPANY SYMBOL NET INCOME Q3/17 LOSS Q3/17 LPS Q3/17 CASH 
Aduro Biotech, Inc. ADRO   -$24.5 M -$0.33 $373.5 M
Applied Genetic Technologies AGTC   -$1.4 M -$0.08 $129.6 M
Asterias Biotherapeutics AST   -$6.8 M -$0.14

$8.6 M

raise of $10.4 M

Athersys, Inc. ATHX   -$7.2 M -$0.06 $28.2 M
Adverum Biotechnologies, Inc. ADVM   -$13.8 M -$0.32 $186.6 M
AxoGen, Inc. AXGN   -$2.1 M -$0.06 $22 M
Bellicum Pharmaceuticals, Inc. BLCM   -$23.4 M -$0.71 $118.6 M
BioLife Solutions, Inc. BLFS   -$425 K -$0.03 $2.8 M
Biostage, Inc. BSTG   Late Filing N/A
BioTime, Inc. BTX   -$14.3 M  -$0.12 $16.6 M
bluebird bio BLUE   -$78.8 M -$1.73 $1.1 B
Brainstorm Cell Therapeutics Inc. BCLI        
Caladrius Biosciences. CLBS   -$3.5 M -$0.38 $59.4 M
Capricor CAPR   -$2.7M  -$0.12 $13.9 M
Cellectis SA CLLS   -$14.2 M -$0.40 $304.1 M
Cesca Therapeutics, Inc KOOL   -$2.4 M -$0.24 $2.6 M
Cytori Therapeutics, Inc. CYTX   -$4.8 M -$0.14 $4.8 M
Fate Therapeutics, Inc. FATE   -$10.7 M  -$0.26 $69.2 M
Fibrocell Science, Inc. FCSC   -$3.8 K -$0.02 $11.9 M
Histogenics Corporation HSGX   -$5.1 M -$0.23 $12.6 M
ImmunoCellular Therapeutics, Ltd. IMUC   -$6,1 M -$0.40 $6 M
International Stem Cell ISCO   -$12.1 M -$0.54 $510 K
Intrexon Corporation XON   -$39.7 M -$0.33 $108.7 M
Juno Therapeutics, Inc. JUNO   -$118.1 M  -$1.12  $1.06 B
Mesoblast Limited MBLTY   -$7 M -$1.60 $69.2 M
MiMedx Group, Inc MDXG +$17.5 M   +0.16 $36.5 M
Neuralstem, Inc.  CUR   -$100 K -$0.01 $14.1 M
Northwest Biotherapeutics, Inc. NWBO        
Organovo Holdings, Inc. ONVO   -$9.5 M -$0.09 $50.7 M
Osiris Therapeutics, Inc. OSIR        
Pluristem Therapeutics, Inc. PSTI   -$7.38 M -$0.08 $12.24 M
ReNeuron Group PLC RENE.L        
Regenxbio RGNX   -$20.7 M -$0.67 $191 M
Sangamo Biosciences, Inc. SGMO   -$12.4 M -$0.15 $253.5 M
Spark Therapeutics, Inc. ONCE   -$65 M -$1.90 $574.9 M
Stemline Therapeutics, Inc. STML   -$16.1 M -$0.68 $79.9 M
uniQure N.V. QURE   -$10.2 M  -$0.40

$88.9 M

10/7 raise  $91.2 M

Verastem, Inc. VSTM   -$23.1 M -$0.61 $60.3 M
Vericel Corporation VCEL   -$5.4 M -$0.16 $15.5 M
VistaGen Therapeutics, Inc. VTGN   -$5.25 M -$0.53 $1.76 M